Please use this identifier to cite or link to this item:
Title: g-Nomic: a new pharmacogenetics interpretation software
Author: Sabater, Ana
Ciudad i Gómez, Carlos Julián
Cendros, Marc
Dobrokhotov, Denis
Sabater i Tobella, Joan, 1934-
Keywords: Farmacogenètica
Marcadors bioquímics
Biochemical markers
Computer software
Issue Date: 29-May-2019
Publisher: Dove Medical Press
Abstract: We present g-Nomic, a pharmacogenetics interpretation software that analyzes globally a prescribed medication taking into account the personal background genetics, drug-drug interactions, lifestyle, nutritional supplements, inhibitors, inducers, and other risks to analyze primary or secondary metabolism pathways. G-Nomic provides a set of recommendations describing the suitability of a given combination of drugs for each patient according to their genes and polymedication. G-Nomic is updated monthly including data from the new drugs to be included, their known interactions, and the relevant pharmacokinetic biomarkers. For the interactions, the list is curated manually, only keeping those with clinical relevance. For each drug, their FDA and EMA drug labels are accessed, to check for relevant enzymes and transport proteins that influence its pharmacokinetics, and for their ability to induce or inhibit other enzymes, particularly the CYP-450 system. When this information is not available, a PubMed search is made to look for these characteristics. In addition, a distinction is made between drugs and prodrugs. A query on the g-Nomic software begins with entering the medication by either their common or commercial name. Non-pharmacological substances can be also added or selected under 'lifestyle habits'. The lifestyle list is dynamic, showing only the substances known to interact with the drugs that are currently selected, and includes herb compounds, such as St. John's wort, as well as proper lifestyle substances such as grapefruit or cigarette smoking. The software provides a list of the genes classified as primary biomarkers as candidates for genetic testing, and a list of the interactions that have been detected. If genetic information is available then, or is made available at a later point, these results can also be entered and the software returns pharmacogenetics recommendations regarding specific genotypes. g-Nomic takes all the above-mentioned parameters in an easy and user-friendly tool making prescription safer.
Note: Reproducció del document publicat a:
It is part of: Pharmacogenomics and Personalized Medicine, 2019, vol. 12, p. 75-85
Related resource:
ISSN: 1178-7066
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)

Files in This Item:
File Description SizeFormat 
690806.pdf3.06 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons